GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Taiantang Pharmaceutical Co Ltd (SZSE:002433) » Definitions » Cyclically Adjusted Revenue per Share

Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Cyclically Adjusted Revenue per Share : ¥3.44 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Guangdong Taiantang Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Guangdong Taiantang Pharmaceutical Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥0.088. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥3.44 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Guangdong Taiantang Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was -7.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -0.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Guangdong Taiantang Pharmaceutical Co was 13.30% per year. The lowest was -0.90% per year. And the median was 5.40% per year.

As of today (2024-06-25), Guangdong Taiantang Pharmaceutical Co's current stock price is ¥0.27. Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥3.44. Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 0.08.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Guangdong Taiantang Pharmaceutical Co was 2.98. The lowest was 0.06. And the median was 1.33.


Guangdong Taiantang Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Taiantang Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Guangdong Taiantang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.19 3.59 3.81 3.73 3.49

Guangdong Taiantang Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.70 3.63 3.56 3.49 3.44

Competitive Comparison of Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Guangdong Taiantang Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guangdong Taiantang Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.088/115.2271*115.2271
=0.088

Current CPI (Mar. 2024) = 115.2271.

Guangdong Taiantang Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.335 98.200 0.393
201409 0.602 98.900 0.701
201412 0.551 99.000 0.641
201503 0.487 99.900 0.562
201506 0.692 99.500 0.801
201509 1.059 100.500 1.214
201512 0.974 100.600 1.116
201603 0.832 102.200 0.938
201606 0.934 101.400 1.061
201609 0.997 102.400 1.122
201612 1.149 102.600 1.290
201703 1.062 103.200 1.186
201706 1.023 103.100 1.143
201709 0.832 104.100 0.921
201712 0.760 104.500 0.838
201803 0.855 105.300 0.936
201806 1.194 104.900 1.312
201809 0.995 106.600 1.076
201812 1.271 106.500 1.375
201903 1.127 107.700 1.206
201906 1.349 107.700 1.443
201909 1.104 109.800 1.159
201912 2.079 111.200 2.154
202003 0.955 112.300 0.980
202006 0.909 110.400 0.949
202009 1.257 111.700 1.297
202012 1.990 111.500 2.057
202103 1.049 112.662 1.073
202106 0.588 111.769 0.606
202109 0.267 112.215 0.274
202112 1.080 113.108 1.100
202203 0.256 114.335 0.258
202206 0.417 114.558 0.419
202209 0.241 115.339 0.241
202212 -0.068 115.116 -0.068
202303 0.181 115.116 0.181
202306 0.163 114.558 0.164
202309 0.148 115.339 0.148
202312 0.042 114.781 0.042
202403 0.088 115.227 0.088

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Guangdong Taiantang Pharmaceutical Co  (SZSE:002433) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.27/3.44
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Guangdong Taiantang Pharmaceutical Co was 2.98. The lowest was 0.06. And the median was 1.33.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Guangdong Taiantang Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Guangdong Taiantang Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Business Description

Traded in Other Exchanges
N/A
Address
No. 888 North Sichuan Road, 25th Floor, Haitai International Building, Hongkou District, Shanghai, CHN, 200080
Guangdong Taiantang Pharmaceutical Co Ltd is a China-based pharmaceutical company engaged in the research, manufacture and sale of high-effect skin-drugs.
Executives
Ke Shao Fang Directors, executives
Hu Qing Guang Director
Song Xiu Qing Director
Ke Shu Quan Director

Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Headlines

No Headlines